Grüntkemeier, Lisa
Khurana, Aditi
Bischoff, Farideh Zamaniyan
Hoffmann, Oliver
Kimmig, Rainer
Moore, Mathew
Cotter, Philip
Kasimir-Bauer, Sabine http://orcid.org/0000-0002-8081-1799
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 9 September 2021
Accepted: 22 December 2021
First Online: 13 January 2022
Declarations
:
: During study performance, FB was employed at Menarini Silicon Biosystem, AK was an employee at RDx working on a contract for Menarini for which the prinicpal invetsogator was FB and LG was paid by Menarini. SKB was (is) a consultant for QIAGEN. Currently, OH is receiving consulting fees from Riemser, Roche, Amgen, Pfizer, Elsai, Hexal, MSD, Novartis and Daiichi Sankyo and RK from Tesaro, Astra-Zeneca and Medtronic, respectively.
: Written informed consent was obtained from all patients and the study was approved by the institutional review board (05/2856 & 16-6915-BO).
: Not applicable.